ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial

André, M.; DE PRIJCK, Bernard; Kentos, A.; Van Hoof, A.; Bonnet, Christophe; Sonet, A.; Maerevoet, M.; Van Den Neste, E.; Bosly, A.; Mounier, N.

Paper published in a journal (Scientific congresses and symposiums)

André, M.; DE PRIJCK, Bernard; Kentos, A. et al.

2014 • In Belgian Journal of Hematology, p. 12

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/167474

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

BHS - 2014 - ABVD (8 cycles) vs BEACOPP....pdf

Publisher postprint (87.39 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Hematology

Author, co-author :

André, M.

DE PRIJCK, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique

Kentos, A.

Van Hoof, A.

Bonnet, Christophe ; Université de Liège - ULiège > GIGA-R : Hématologie

Sonet, A.

Maerevoet, M.

Van Den Neste, E.

Bosly, A.

Mounier, N.

Language :

English

Title :

ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial

Publication date :

2014

Event name :

29th General Annual Meeting of the Belgian Hematological Society

Event date :

du 30 janvier 2014 au 1er février 2014

Journal title :

Belgian Journal of Hematology

ISSN :

2033-3749

Publisher :

Ariez Medical Publishing, Amsterdam, Netherlands

Pages :

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 14 May 2014

Statistics

Number of views

104 (4 by ULiège)

Number of downloads

41 (0 by ULiège)

More statistics